TAK-500
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-500, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]